APA

Reynolds J. A., Briggs T. A., Rice G. I., Darmalinggam S., Bondet V., Bruce E., Khan M., Haque S., Chinoy H., Herrick A. L., McCarthy E. M., Zeef L., Hayes A., Duffy D., Parker B. & Bruce I. N. (20200529). Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles. : Arthritis research & therapy.

Chicago

Reynolds John A, Briggs Tracy A, Rice Gillian I, Darmalinggam Sathya, Bondet Vincent, Bruce Ellen, Khan Mumtaz, Haque Sahena, Chinoy Hector, Herrick Ariane L, McCarthy Eoghan M, Zeef Leo, Hayes Andrew, Duffy Darragh, Parker Ben and Bruce Ian N. 20200529. Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles. : Arthritis research & therapy.

Harvard

Reynolds J. A., Briggs T. A., Rice G. I., Darmalinggam S., Bondet V., Bruce E., Khan M., Haque S., Chinoy H., Herrick A. L., McCarthy E. M., Zeef L., Hayes A., Duffy D., Parker B. and Bruce I. N. (20200529). Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles. : Arthritis research & therapy.

MLA

Reynolds John A, Briggs Tracy A, Rice Gillian I, Darmalinggam Sathya, Bondet Vincent, Bruce Ellen, Khan Mumtaz, Haque Sahena, Chinoy Hector, Herrick Ariane L, McCarthy Eoghan M, Zeef Leo, Hayes Andrew, Duffy Darragh, Parker Ben and Bruce Ian N. Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles. : Arthritis research & therapy. 20200529.